Biotech | June 01, 2022
Novavax initiates phase 3 trial of its COVID-19 omicron booster
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Five patient-first principles to provide the highest standard of healthcare
‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Subscribe To Our Newsletter & Stay Updated
